Published in CMAJ on November 09, 2004
Pneumomastia: a rare cause of breast swelling. Breast Care (Basel) (2013) 0.75
Spontaneous pneumomediastinum: clinical and natural history. Ann Emerg Med (1992) 3.03
Spontaneous pneumomediastinum: a rare benign entity. J Thorac Cardiovasc Surg (2003) 1.28
Radiographic and CT demonstration of mammary emphysema. J Comput Assist Tomogr (1985) 1.03
Emphysema of the breast simulating fibroadenolipoma. AJR Am J Roentgenol (1994) 0.93
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) (2006) 3.03
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension (2007) 2.90
Short- and long-term incidence of stroke in white-coat hypertension. Hypertension (2004) 2.58
Ambulatory arterial stiffness index: merits and limitations of a simple surrogate measure of arterial compliance. J Hypertens (2008) 1.66
Heritability of central blood pressure and arterial stiffness: a twin study. J Hypertens (2012) 1.45
Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. Am J Hypertens (2007) 1.43
Pressure-independent relationship of aortic characteristic impedance with left ventricular mass and geometry in untreated hypertension. J Hypertens (2015) 1.43
Decreasing cardiovascular risk in HIV infection between 2005 and 2011. AIDS (2014) 1.39
Are observational studies more informative than randomized controlled trials in hypertension? Con side of the argument. Hypertension (2013) 1.38
CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation (2004) 1.36
Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J Hypertens (2013) 1.36
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol (2006) 1.36
Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis Rheum (2005) 1.25
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19
Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol (2012) 1.19
The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy. J Electrocardiol (2010) 1.12
Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens (2007) 1.10
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res (2008) 1.05
Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci (2005) 1.01
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study. J Infect (2008) 1.00
Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis (2007) 0.97
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol (2002) 0.97
Is estimated cardiovascular risk higher in HIV-infected patients than in the general population? Scand J Infect Dis (2007) 0.95
Oxidation injury in patients receiving HMG-CoA reductase inhibitors: occurrence in patients without enzyme elevation or myopathy. Drug Saf (2002) 0.94
Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res (Hoboken) (2010) 0.94
Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis (2005) 0.90
Renal denervation for resistant hypertension. N Engl J Med (2014) 0.90
Capillary rarefaction and abnormal cardiovascular reactivity in hypertension. J Hypertens (2003) 0.90
Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. Nutr Metab Cardiovasc Dis (2006) 0.90
Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb (2012) 0.89
Blood pressure variability: an additional target for antihypertensive treatment? Hypertension (2011) 0.89
Prognostic value of low and high ankle-brachial index in hospitalized medical patients. Eur J Intern Med (2011) 0.89
Second statement of the working group on electrocardiographic diagnosis of left ventricular hypertrophy. J Electrocardiol (2011) 0.88
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. Am J Hypertens (2013) 0.87
Non-pharmacological control of plasma cholesterol levels. Nutr Metab Cardiovasc Dis (2008) 0.86
Prostaglandin E1 improves endothelial function in critical limb ischemia. J Cardiovasc Pharmacol (2003) 0.86
Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients. J Hypertens (2013) 0.84
Assessing cardiovascular risk: should we discard diastolic blood pressure? Circulation (2009) 0.84
Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia. Metabolism (2003) 0.84
Association of body mass index with arterial stiffness and blood pressure components: a twin study. Atherosclerosis (2013) 0.83
Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil (2004) 0.83
Progression of renal artery stenosis after renal denervation. Impact on 24-hour blood pressure. Circ J (2013) 0.83
Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries. Metabolism (2007) 0.83
Metabolic syndrome: at the crossroads of cardiorenal risk. J Nephrol (2009) 0.82
Determinants of blood pressure variability in youth: at the roots of hypertension. J Hypertens (2010) 0.82
Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Curr Pharm Des (2015) 0.81
Evidence for a strong genetic influence on carotid plaque characteristics: an international twin study. Stroke (2012) 0.81
Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function. J Cardiovasc Pharmacol Ther (2009) 0.80
Human endothelial impairment in sepsis. Atherosclerosis (2007) 0.80
Negative influence of HIV infection on day-night blood pressure variability. J Acquir Immune Defic Syndr (2010) 0.80
Left ventricular hypertrophy reversal and prevention of diabetes: two birds with one stone? Hypertension (2007) 0.80
Cardiovascular risk factors and recommended lipid goals attainment among patients referred in a tertiary care lipid clinic. Eur J Intern Med (2011) 0.80
Carotid-femoral pulse wave velocity assessment using novel cuff-based techniques: comparison with tonometric measurement. J Hypertens (2013) 0.80
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. J Rheumatol (2007) 0.80
Acute renal failure and metabolic alkalosis in a patient with colorectal villous adenoma (McKittrick-Wheelock syndrome). Surgery (2012) 0.79
Effect of body weight changes on 24-hour blood pressure and left ventricular mass in hypertension: a 4-year follow-up. Am J Hypertens (2003) 0.79
Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias. Metabolism (2003) 0.79
Obstructive Sleep Apnea and Cardiovascular Disease - A New Target for Treatment. Curr Pharm Des (2015) 0.79
Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrocardiographic myocardial ischemia and patients with healed myocardial infarction. Am J Cardiol (2004) 0.79
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study. J Hypertens (2017) 0.78
Central and 24-h blood pressure: dwarfs standing upon the shoulders of giants? J Hypertens (2011) 0.78
Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia. Am J Cardiol (2002) 0.78
From hypertension to hypertrophy to heart failure: the role of cardiotrophin-1. J Hypertens (2013) 0.78
Racial difference in endothelial function: role of the infective burden. Atherosclerosis (2006) 0.78
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement. J Cardiovasc Med (Hagerstown) (2006) 0.78
The use of osteopathic manipulative treatment as adjuvant therapy in patients with peripheral arterial disease. Man Ther (2008) 0.78
Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. Metabolism (2008) 0.78
Cervical spondylodiscitis with spinal epidural abscess caused by Aggregatibacter aphrophilus. J Med Microbiol (2008) 0.78
D-dimer and duration of anticoagulation. N Engl J Med (2007) 0.77
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. Ital Heart J (2003) 0.77
Pharmacogenomics of left ventricular hypertrophy reversal: beyond the 'one size fits all' approach to antihypertensive therapy. J Hypertens (2004) 0.77
Acute inflammatory state during influenza infection and endothelial function. Atherosclerosis (2005) 0.77
Different roles for anti-cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid arthritis: comment on the article by Farragher et al. Arthritis Rheum (2009) 0.77
An endogenous brake on the sympathetic nervous system: the emerging role of catestatin in hypertension. J Cardiovasc Med (Hagerstown) (2011) 0.77
Estimate of white-coat effect and arterial stiffness. J Hypertens (2007) 0.76
Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. Ann N Y Acad Sci (2005) 0.76
Right ventricular hypertrophy in systemic hypertension: an updated review of clinical studies. J Hypertens (2013) 0.76
Association between thyroid hormone levels, the number of circulating osteoprogenitor cells, and bone mineral density in euthyroid postmenopausal women. Metabolism (2011) 0.76
Treating hypertensive non-dippers: additional benefit from nocturnal blood pressure reduction? Cardiovasc Drugs Ther (2005) 0.75
Twenty-four-hour ambulatory central blood pressure: new perspectives for blood pressure measurement? J Hypertens (2014) 0.75
On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: impact on carotid intima-media thickness. Life Sci (2013) 0.75
Genetic influence on the relation between exhaled nitric oxide and pulse wave reflection. J Breath Res (2013) 0.75
Long-term weight loss and blood pressure reduction: the perfect is the enemy of the good. Am J Hypertens (2006) 0.75
Genetic and environmental factors on the relation of lung function and arterial stiffness. Respir Med (2013) 0.75
Pulmonary venous flow in hypertension: ready for prime time? J Hypertens (2008) 0.75
Aerobic physical exercise and arterial de-stiffening: a recipe for vascular rejuvenation? Hypertens Res (2012) 0.75
The emerging role of atherosclerotic cardiovascular disease in systemic lupus erythematosus. Nutr Metab Cardiovasc Dis (2009) 0.75
Response to are observational studies more informative than randomized controlled trials in hypertension? Pro side of the argument. Hypertension (2013) 0.75
Hypertension in HIV patients. AIDS (2006) 0.75
Antihypertensive treatment and left ventricular mass reduction: the importance of choosing the comparator. Hypertension (2009) 0.75
Serum triglyceride concentration and coronary heart disease. Circulation (2002) 0.75
The difficult art of detecting left ventricular hypertrophy in obesity: not all ECG criteria are created equal. J Hypertens (2013) 0.75
Assessing vascular benefits of tetrahydrobiopterin supplementation: does analytical method matter? Am J Hypertens (2013) 0.75
Central blood pressure: getting to the heart of the matter. J Hypertens (2010) 0.75
What are the real determinants of the ambulatory arterial stiffness index? J Hypertens (2012) 0.75